Man Li

454 total citations
23 papers, 349 citations indexed

About

Man Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Man Li has authored 23 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Man Li's work include RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and Advanced Breast Cancer Therapies (3 papers). Man Li is often cited by papers focused on RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and Advanced Breast Cancer Therapies (3 papers). Man Li collaborates with scholars based in China, United States and South Africa. Man Li's co-authors include Zhen Liang, Lijuan Zou, Yukui Zhang, Zuowei Zhao, Huiming Yuan, Simin Xia, Yanyan Qu, Lihua Zhang, Qi Wu and Lingzhi Xu and has published in prestigious journals such as Biomaterials, Analytical Chemistry and Cell Death and Differentiation.

In The Last Decade

Man Li

22 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Man Li China 10 260 81 52 50 40 23 349
Sungwon Bae South Korea 8 191 0.7× 54 0.7× 49 0.9× 31 0.6× 24 0.6× 12 334
Derek J. Hoelz United States 9 278 1.1× 93 1.1× 60 1.2× 45 0.9× 24 0.6× 15 387
Kevin Conlon United States 11 315 1.2× 89 1.1× 47 0.9× 41 0.8× 26 0.7× 21 458
Sara L. O’Kane United Kingdom 10 237 0.9× 119 1.5× 84 1.6× 24 0.5× 98 2.5× 17 436
Max Jacobsen United States 12 257 1.0× 68 0.8× 85 1.6× 46 0.9× 58 1.4× 21 412
Erina Iwabuchi Japan 12 203 0.8× 93 1.1× 73 1.4× 27 0.5× 52 1.3× 34 361
Loukia Georgiou Karacosta United States 6 257 1.0× 134 1.7× 113 2.2× 46 0.9× 46 1.1× 12 367
Valentina Fodale Italy 9 265 1.0× 72 0.9× 59 1.1× 30 0.6× 16 0.4× 13 378
Brendan T. Finicle United States 8 291 1.1× 68 0.8× 157 3.0× 85 1.7× 38 0.9× 9 462
Soumen Kahali United States 8 373 1.4× 92 1.1× 157 3.0× 60 1.2× 48 1.2× 9 539

Countries citing papers authored by Man Li

Since Specialization
Citations

This map shows the geographic impact of Man Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Li more than expected).

Fields of papers citing papers by Man Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Li. The network helps show where Man Li may publish in the future.

Co-authorship network of co-authors of Man Li

This figure shows the co-authorship network connecting the top 25 collaborators of Man Li. A scholar is included among the top collaborators of Man Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man Li. Man Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jianbin, Shu Wang, Shaohua Zhang, et al.. (2025). Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2. PubMed. 6. 21–21. 1 indexed citations
2.
Hu, Guo-Sheng, Man Li, Ziying Wang, et al.. (2025). Two-photon photosensitizer for specific targeting and induction of tumor pyroptosis to elicit systemic immunity-boosting anti-tumor therapy. Biomaterials. 317. 123108–123108. 5 indexed citations
3.
Wang, Jing, et al.. (2023). MiR-181c-5p Regulates Lung Adenocarcinoma Progression via Targeting PRKN. Biochemical Genetics. 62(2). 1103–1114. 3 indexed citations
5.
Chen, Fengxi, et al.. (2022). Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer. Frontiers in Surgery. 9. 837848–837848. 6 indexed citations
6.
Zhang, Shu, Dongdong Qin, Liwen Wu, et al.. (2021). Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy. Orphanet Journal of Rare Diseases. 16(1). 188–188. 23 indexed citations
7.
Zhang, Jinrui, Shuyan Liu, Qiong Li, et al.. (2020). The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death and Differentiation. 27(9). 2710–2725. 38 indexed citations
8.
Li, Man, et al.. (2020). TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway. Biochemical Genetics. 58(6). 953–965. 5 indexed citations
9.
Xu, Lingzhi, Fan Xu, Ting Yang, et al.. (2020). Inhibition of p62/SQSTM1 sensitizes small‐cell lung cancer cells to cisplatin‐induced cytotoxicity by targeting NEDD9 expression. Molecular Carcinogenesis. 59(8). 967–979. 9 indexed citations
10.
Zhao, Zheng, Tao Fu, Yang Xu, et al.. (2020). Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors. Journal of Medical Genetics. 58(2). 79–86. 11 indexed citations
11.
Li, Xuelu, et al.. (2019). Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer. Cancer Biomarkers. 25(1). 19–27. 9 indexed citations
12.
Wang, Peng, Ying Gong, Tao Guo, et al.. (2019). Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death and Disease. 10(6). 432–432. 52 indexed citations
13.
Song, Chen, Ning Wang, Tao Qin, et al.. (2019). RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness. Carcinogenesis. 41(9). 1294–1305. 13 indexed citations
14.
Li, Xuelu, Xiaoqing Song, Jing Ma, et al.. (2019). FSIP1 is correlated with estrogen receptor status and poor prognosis. Molecular Carcinogenesis. 59(1). 126–135. 4 indexed citations
15.
Li, Man, Hailing Lu, Xiaolian Liu, et al.. (2018). Overexpression of 14‑3‑3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma. Oncology Letters. 16(1). 1051–1058. 1 indexed citations
16.
Qin, Tao, Silei Sui, Chen Song, et al.. (2017). Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1. Biomedicine & Pharmacotherapy. 95. 649–655. 32 indexed citations
17.
Tang, Ranran, Xiangdong Xu, Wenjing Yang, et al.. (2016). MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. Cancer Letters. 373(1). 77–87. 28 indexed citations
18.
Xu, Yue, Zhifeng Gu, Biyu Shen, et al.. (2012). Roles of Wnt/β-Catenin Signaling in Retinal Neuron-Like Differentiation of Bone Marrow Mesenchymal Stem Cells from Nonobese Diabetic Mice. Journal of Molecular Neuroscience. 49(2). 250–261. 18 indexed citations
20.
Nai, Qiang, Xiaoyun Wang, Ying Jin, et al.. (2009). Ciliary neurotrophic factor enhances nicotinic synaptic transmission in sympathetic neurons. Journal of Neuroscience Research. 88(4). 887–895. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026